[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]
IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
1981 | 0 | 1 | 1 | 0 | 0 | |||||||||||||
1982 | 0 | 1 | 2 | 0 | 0 | |||||||||||||
2010 | 0 | 0.51 | 0 | 0 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.29 | |||||
2011 | 0 | 0.6 | 0 | 0 | 2 | 6 | 2 | 0 | 2 | 2 | 0 | 0 | 0.35 | |||||
2012 | 0.25 | 0.65 | 0.29 | 0.25 | 1 | 7 | 1 | 2 | 2 | 4 | 1 | 4 | 1 | 0 | 1 | 1 | 0.34 | |
2013 | 0.33 | 0.64 | 0.13 | 0.2 | 1 | 8 | 12 | 1 | 3 | 3 | 1 | 5 | 1 | 0 | 0 | 0.34 | ||
2014 | 0 | 0.65 | 0 | 0 | 2 | 10 | 0 | 3 | 2 | 6 | 0 | 0 | 0.34 | |||||
2015 | 0 | 0.63 | 0 | 0 | 1 | 11 | 0 | 3 | 3 | 8 | 0 | 0 | 0.35 |
IF: | Two years Impact Factor: C2Y / D2Y |
AIF: | Average Impact Factor for all series in RePEc in year y |
CIF: | Cumulative impact factor |
IF5: | Five years Impact Factor: C5Y / D5Y |
DOC: | Number of documents published in year y |
CDO: | Cumulative number of documents published until year y |
CIT: | Number of citations to papers published in year y |
NCI: | Number of citations in year y |
CCU: | Cumulative number of citations to papers published until year y |
D2Y: | Number of articles published in y-1 plus y-2 |
C2Y: | Cites in y to articles published in y-1 plus y-2 |
D5Y: | Number of articles published in y-1 until y-5 |
C5Y: | Cites in y to articles published in y-1 until y-5 |
SC: | selft citations in y to articles published in y-1 plus y-2 |
%SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
CiY: | Cites in year y to documents published in year y |
II: | Immediacy Index: CiY / Documents. |
AII: | Average Immediacy Index for series in RePEc in year y |
# | Year | Title | Cited |
---|---|---|---|
1 | 2013 | Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Sussex, J ; Barnsley, P. In: Occasional Papers. RePEc:ohe:occpap:000106. Full description at Econpapers || Download paper | 13 |
2 | 1982 | Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry. (1982). Hartley, Keith ; Maynard, A. In: Occasional Papers. RePEc:ohe:occpap:000332. Full description at Econpapers || Download paper | 3 |
3 | 2012 | The Use of Pay-for-Performance for Drugs: Can It Improve Incentives for Innovation?. (2012). Towse, Adrian ; Puig-Peiro, R ; Garrison, L. In: Occasional Papers. RePEc:ohe:occpap:000167. Full description at Econpapers || Download paper | 2 |
4 | 1981 | Price Comparisons of Identical Products in Japan, the United States and Europe. (1981). Reekie, W D. In: Occasional Papers. RePEc:ohe:occpap:000322. Full description at Econpapers || Download paper | 2 |
5 | 2011 | Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution?. (2011). Towse, Adrian ; Garau, Martina ; Danzon, Patricia. In: Occasional Papers. RePEc:ohe:occpap:000191. Full description at Econpapers || Download paper | 2 |
6 | 2010 | New Drugs to Tackle Antimicrobial Resistance: EU Policy Options. (2010). Towse, Adrian ; Sharma, P. In: Occasional Papers. RePEc:ohe:occpap:000216. Full description at Econpapers || Download paper | 1 |
7 | 2011 | Critical Review of the Quality and Competition Measures and Identification Strategies Used in Health Care Studies. (2011). Mordoh, A. In: Occasional Papers. RePEc:ohe:occpap:000171. Full description at Econpapers || Download paper | 1 |
# | Year | Title | Cited |
---|---|---|---|
1 | 2013 | Critique of CHE Research Paper 81: Methods for the Estimation of the NICE Cost Effectiveness Threshold. (2013). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Sussex, J ; Barnsley, P. In: Occasional Papers. RePEc:ohe:occpap:000106. Full description at Econpapers || Download paper | 4 |
Year | Title |
---|